Clinical Trial Update: A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients [Phase 1]

View source ↗

Summary

Phase I study evaluating intravenous aflibercept in combination with docetaxel in Japanese cancer patients; focuses on safety, tolerability, and preliminary dos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Aflibercept (Aflibercept)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Neoplasms | Phase 1 | Status: COMPLETED